ROYAL LONDON ASSET MANAGEMENT LTD
Position in GILD — Gilead Sciences, Inc.
CIK 863748
UNITED KINGDOM, X0
Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$69,722,876
-$9,903,804 QoQ
Shares Held
551,867
-3.4% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#176
of 2,275 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROYAL LONDON ASSET MANAGEMENT LTD holds $4,029,879,846 across 10 Drug Manufacturers - General names. GILD ranks #7 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
10,161,026 | $1,926,733,750 | |
| 2 | LLY |
ELI LILLY & Co
|
645,864 | $774,668,722 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,987,037 | $383,834,254 | |
| 4 | ABBV |
AbbVie Inc.
|
1,342,483 | $337,822,422 | |
| 5 | JNJ |
Johnson & Johnson
|
1,189,474 | $302,090,711 | |
| 6 | AMGN |
Amgen Inc
|
280,510 | $101,578,281 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
551,867 | $69,722,876 | |
| 8 | PFE |
Pfizer Inc
|
2,819,076 | $67,883,350 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $69,722,876 | 551,867 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $79,626,680 | 571,333 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $67,769,295 | 552,137 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $61,707,564 | 555,924 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $63,330,939 | 571,218 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $65,280,105 | 582,598 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $65,283,883 | 706,765 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $73,526,170 | 876,982 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $61,715,312 | 899,509 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $89,528,640 | 1,222,234 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $84,645,323 | 1,044,875 | Shares | Sole | 2024-03-01 | |
| 2023-09-30 | $63,199,150 | 843,330 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $47,755,346 | 619,636 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $48,073,066 | 579,403 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $54,148,256 | 630,731 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $38,351,500 | 621,681 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $40,418,300 | 653,912 | Shares | Sole | 2022-09-06 | |
| 2022-03-31 | $38,958,595 | 655,317 | Shares | Sole | 2022-09-06 | |
| 2021-12-31 | $45,766,518 | 630,306 | Shares | Sole | 2022-10-18 | |
| 2021-09-30 | $45,914,570 | 657,331 | Shares | Sole | 2022-10-18 | |
| 2021-06-30 | $46,456,949 | 674,658 | Shares | Sole | 2022-10-18 | |
| 2021-03-31 | $44,729,582 | 692,087 | Shares | Sole | 2022-10-17 | |
| 2020-12-31 | $39,067,524 | 670,572 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $42,327,884 | 669,851 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $51,678,289 | 671,670 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $51,586,867 | 690,033 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||